Results 91 to 100 of about 822 (142)

Inhibition mechanism of the fungal β-1,3-glucan synthases by triterpenoid antifungal drugs. [PDF]

Nat Commun
You ZL, Sun L, Wang LX, Ni YR, Lyu RQ, Chen DD, Yun CH, Song T, Song Y, Bai L.   +9 more
europepmc   +1 more source

Past, present and future of antifungals: Advancements in mechanisms of action and resistance. [PDF]

Curr Res Microb Sci
Santos ALS, Rodrigues CF, Roudbary M, Branquinha MH.   +3 more
europepmc   +1 more source

Studying Candida Biofilms Across Species: Experimental Models, Structural Diversity, and Clinical Implications. [PDF]

Pharmaceuticals (Basel)
Squitieri D, Rizzo S, Torelli R, Mariotti M, Sanguinetti M, Cacaci M, Bugli F.   +6 more
europepmc   +1 more source

SCY-247, a novel second-generation triterpenoid antifungal, demonstrates high in vitro activity against genetically diverse Candida auris isolates, including FKS1 mutants. [PDF]

J Antimicrob Chemother
Spruijtenburg B, de Groot T, Meijer EFJ.
europepmc   +1 more source

<i>In vitro</i> activity of novel antifungals, natamycin, and terbinafine against <i>Fusarium</i>. [PDF]

Antimicrob Agents Chemother
Garbe E, Ullah A, Aldejohann AM, Kurzai O, Janevska S, Walther G.   +5 more
europepmc   +1 more source

ZfpA-regulated chitin synthesis in <i>Aspergillus fumigatus</i> hyphae determines fungicidal tip lysis by FksA-targeting antifungals. [PDF]

Antimicrob Agents Chemother
Calise DG, Michaelis ML, Park SC, Wagner AS, Keller NP.   +4 more
europepmc   +1 more source

Identification and antifungal susceptibility patterns of reference yeast strains to novel and conventional agents: a comparative study using CLSI, EUCAST and Sensititre YeastOne methods. [PDF]

JAC Antimicrob Resist
Ceballos-Garzon A, Holzapfel M, Welsch J, Mercer D.   +3 more
europepmc   +1 more source

Current and emerging therapies for fungal biofilms and systemic infections. [PDF]

Crit Rev Microbiol
Elgammal Y, Garcia Martinez RI, Requejo A, Martinez LR.   +3 more
europepmc   +1 more source

Pharmacological advances in <i>Candida auris</i>: emerging antifungal mechanisms and next-generation therapeutic strategies. [PDF]

J Enzyme Inhib Med Chem
Hudu SA, Saadi N, Morad EA, Tahir A, Jimoh AO.   +4 more
europepmc   +1 more source

Genomic Insights of <i>Candida krusei</i>, an Emerging Fungal Pathogen With Intrinsic Antifungal Resistance. [PDF]

Open Forum Infect Dis
Jain K, Wadhwa K, Malik M, Haque S, Prieto MA, Kaur H.   +5 more
europepmc   +1 more source